AhR regulation of amyloid beta-induced inflammation in astrocyte cells

QR Code

AhR regulation of amyloid beta-induced inflammation in astrocyte cells

IntroductionAmyloid beta (Aβ) plaques, tau tangles, and neuroinflammation are common features present in Alzheimer’s Disease (AD), and glial cells are essential mediators of the inflammatory reaction. Aryl hydrocarbon receptor (AhR), a transcription factor engaged in regulation of immune function, m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Emmanuel Ojo, Temitope Adu, Raheem F. H. AI Aameri, Shelley A. Tischkau
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Cellular Neuroscience
Subjects:	Alzheimer’s Disease (AD) amyloid beta (Aβ) astrocytes inflammation cytokines immune response
Online Access:	https://www.frontiersin.org/articles/10.3389/fncel.2025.1618209/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025-04-01)

Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: A meta-analysis
by: Fatemeh Sedghi, et al.
Published: (2025-12-01)

Beneficial Influence of Agomelatine Treatment on Behavioral Impairments in AΒ-Induced Rat Model of Alzheimer’s Disease
by: Kalina Ilieva, et al.
Published: (2020-12-01)

Amyloid β 1-42 Can Form Ion Channels as Small as Gramicidin in Model Lipid Membranes
by: Yue Xu, et al.
Published: (2025-07-01)

Catalpol alleviates amyloid- generation and neuronal oxidative stress injury via activating the Keap1-Nrf2/ARE signaling pathway in the immortalized lymphocytes from patients with late-onset Alzheimer’s disease and SKNMC cells co-culture model
by: Caixia Xiang, et al.
Published: (2024-12-01)

Human iPSC-derived cerebral organoids reveal oxytocin-mediated protection against amyloid-β pathology
by: Tomoki Asaba, et al.
Published: (2025-12-01)

Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes
by: Katelynn E. Krick, et al.
Published: (2025-09-01)

Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's disease
by: Benjamin Siciliano, et al.
Published: (2025-08-01)

Astrocytes: Therapeutic targets for stroke
by: Jingxiu Li, et al.
Published: (2026-03-01)

Administration of Polyphenol-Rich Sugarcane Extract Alleviates Deficits Induced by Amyloid-Beta<sub>1–42</sub> (Aβ<sub>1–42</sub>) in Transgenic <i>C. elegans</i>
by: Deniz Heydarian, et al.
Published: (2025-04-01)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
by: I. K. Malashenkova, et al.
Published: (2018-06-01)

Associations of Plasma and CSF Osteocalcin Levels With CSF ATN Biomarkers and Cognitive Functions in Alzheimer's Disease
by: Xian‐Le Bu, et al.
Published: (2025-07-01)

Rising of intracellular NAD+ level and oppositely directed changes in CD38 expression in hippocampal cells in experimental Alzheimer’s disease
by: A. A. Semenova, et al.
Published: (2021-10-01)

Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease
by: Sagar S. Bachhav, et al.
Published: (2025-07-01)

Development of perivascular astrocyte processes
by: Martine Cohen-Salmon, et al.
Published: (2025-07-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer’s Disease Pathophysiology
by: Kerry Rennie
Published: (2025-06-01)

Role of the chaperonin TCP-1 ring complex in protein aggregation and neurodegeneration
by: Vanlalrinchhani Varte, et al.
Published: (2025-07-01)

Autophagy and Alzheimer’s Disease: Mechanisms and Impact Beyond the Brain
by: Zaw Myo Hein, et al.
Published: (2025-06-01)

Rest‐activity rhythm characteristics associated with lower cognitive performance and Alzheimer's disease biomarkers in midlife women
by: Alexandra Paget‐Blanc, et al.
Published: (2025-04-01)

Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation
by: Marta Matuszewska, et al.
Published: (2025-07-01)

A splice‐switching antisense oligonucleotide targeting APP reduces accumulation of α‐synuclein in a mouse model of Parkinson's disease
by: Rijwan U. Ahammad, et al.
Published: (2025-04-01)

Anti-Amyloid Aggregation Effects of Gobaishi (<i>Galla chinensis</i>) and Its Active Constituents
by: Sharmin Akter, et al.
Published: (2025-06-01)

The Role of Astrocytes in Poststroke Rehabilitation
by: Ying Han, et al.
Published: (2025-06-01)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
by: Xiaojuan Li, et al.
Published: (2025-04-01)

New Possibilities for Evaluating Markers of Alzheimer's Disease in Blood Serum
by: S. V. Vorobev, et al.
Published: (2025-06-01)

Reactive astrocytes and glioblastoma: are there new targets for more effective antitumor therapy?
by: E. E. Tyagunova, et al.
Published: (2023-09-01)

Dietary docosahexaenoic acid and dihydrocaffeic acid, a chlorogenic acid derivative, confer additive neuroprotection against β-amyloid in SH-SY5Y cells
by: Edwin Estefan Reza-Zaldívar, et al.
Published: (2025-12-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01)

Anagliptin protects neuronal cells against endogenous amyloid β (Aβ)-induced cytotoxicity and apoptosis
by: Zhenbo Chen, et al.
Published: (2019-12-01)

The effect of oral administration of NXP032 equivalent to intraperitoneal administration in an Alzheimer’s disease model
by: Jae Min Lee, et al.
Published: (2025-07-01)

Toxicity of glyphosate accelerates neurodegeneration in Caenorhabditis elegans model of Alzheimer’s disease
by: Nisha Rani, et al.
Published: (2025-07-01)

Why testing and diagnosis for Alzheimer's disease are mission critical
by: Brent W. Beasley
Published: (2025-04-01)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
by: Xiang‐Sha Yin, et al.
Published: (2025-04-01)

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
by: Ryosuke Shimasaki, et al.
Published: (2025-07-01)

Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
by: Aleksey A. Kulesh, et al.
Published: (2017-10-01)

Obstructive sleep apnea and amyloid-β42 in adolescents: The results of a pilot study
by: O. N. Berdina, et al.
Published: (2022-07-01)

Analytical and clinical validation of a high accuracy fully automated digital immunoassay for plasma phospho-Tau 217 for clinical use in detecting amyloid pathology
by: David Wilson, et al.
Published: (2025-07-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)